COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS: APPROACHES TO ANTIBACTERIAL THERAPY IN THE CONTEXT OF CURRENT CLINICAL GUIDELINES

被引:0
作者
Sinopalnikov, A. I. [1 ]
机构
[1] Minist Def Russian Federat, State Inst Qualificat Improvement Phys, Moscow, Russia
关键词
community-acquired pneumonia; antibacterial therapy; clinical guidelines; MANAGEMENT; SEVERITY; DIAGNOSIS; STABILITY; OUTCOMES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Conciliatory guidelines for management of patients with either disease/abnormality have recently become an integral part of medical practice. The popularity of the guidelines is likely to owe to the fact that they are a more or less successful synthesis of abundant information within one document, by giving a physician detailed many-year and many-decade clinical and scientific experience. Since their publication, they become a peculiar standard of medical care delivery. The main benefit of such guidelines should be seen in the diagnosis and treatment standardization (without a physician's losing his/her reasonable autonomy in each individual case) that makes it possible to optimize a diagnostic process, to apply more effective therapeutic approaches, and to use less health care resources. By taking into account the drastically changing epidemiology of resistance of the causative agents of respiratory tract infection, the emergence of new antibiotics, and the rethinking of conventional diagnostic and therapeutic approaches, there is an apparent need for periodic revision and modification of such guidelines. In this regard, of particular interest are the conciliatory guidelines of the Russian Respiratory Society and Interregional Association of Clinical Microbiology and Antimicrobial Chemotherapy, which were published in 2010.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 18 条
  • [1] [Anonymous], COCHRANE DATABASE SY
  • [2] CHARLES PGP, 2007, 47 ICAAC CHIC
  • [3] CHARLES PGP, 2006, 46 ICAAC SAN FRANC
  • [4] CHUCHALIN AG, 2006, VNEBOLNICHNAYA PNEVM
  • [5] High-dose, short-course Levofloxacin for community-acquired pneumonia: A new treatment paradigm
    Dunbar, LM
    Wunderink, RG
    Habib, MP
    Smith, LG
    Tennenberg, AM
    Khashab, MM
    Wiesinger, BA
    Xiang, JX
    Zadeikis, N
    Kahn, JB
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (06) : 752 - 760
  • [6] Optimal treatment strategies for community-acquired pneumonia: Non-responders to conventional regimens
    File, TM
    [J]. CHEMOTHERAPY, 2001, 47 : 11 - 18
  • [7] A prediction rule to identify low-risk patients with community-acquired pneumonia
    Fine, MJ
    Auble, TE
    Yealy, DM
    Hanusa, BH
    Weissfeld, LA
    Singer, DE
    Coley, CM
    Marrie, TJ
    Kapoor, WN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (04) : 243 - 250
  • [8] Time to clinical stability in patients hospitalized with community-acquired pneumonia - Implications for practice guidelines
    Halm, EA
    Fine, MJ
    Marrie, TJ
    Coley, CM
    Kapoor, WN
    Obrosky, DS
    Singer, DE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18): : 1452 - 1457
  • [9] Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia
    Houck, PM
    Bratzler, DW
    Nsa, W
    Ma, A
    Bartlett, JG
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (06) : 637 - 644
  • [10] British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009
    Lim, W. S.
    Baudouin, S. V.
    George, R. C.
    Hill, A. T.
    Jamieson, C.
    Le Jeune, I.
    Macfarlane, J. T.
    Read, R. C.
    Roberts, H. J.
    Levy, M. L.
    Wani, M.
    Woodhead, M. A.
    [J]. THORAX, 2009, 64 : 1 - 55